Correction: Five-year survival prognosis of young, middle-aged, and elderly adult female invasive breast cancer patients by clinical and lifestyle characteristics Yu-Tung TengYong Alison WangJason J. Liu Correction Open access 02 May 2024
Ten-year trend analysis of breast cancer, oncoplastic, and reconstructive breast surgery in a single institution (2010–2019), what has not changed? A. MoradK. JohnsonJ. Harvey Research 30 April 2024
Risk of first recurrence after treatment in a population-based cohort of young women with breast cancer Robin SchaffarSimone BenhamouElisabetta Rapiti Research Open access 30 April 2024
Circulating microRNAs and therapy-associated cardiac events in HER2-positive breast cancer patients: an exploratory analysis from NeoALTTO S. PizzamiglioC. M. CiniselliS. Di Cosimo Clinical trial Open access 30 April 2024
Clinico–pathologic factors and survival of patients with breast cancer diagnosed with de novo brain metastasis: a national cancer database analysis Ali HijaziMohamed MohannaZeina Nahleh Research Open access 29 April 2024
Neoadjuvant chemotherapy for triple-negative and Her2 +ve breast cancer: striving for the standard of care Amanda RobertsJulie HalletNicole J. Look Hong Preclinical study 27 April 2024
A systematic review and meta-analysis of diagnostic performance of fluorescein-guided sentinel lymph node biopsy in early breast cancer Sanjay Kumar YadavS. BharathAmit Goyal Review 26 April 2024
Unveiling the potential of breast MRI: a game changer for BI-RADS 4A microcalcifications Shiping LiYihao LinYinlong Yang Research 26 April 2024
Perspectives on shorter durations of anti-HER2 therapy in early-stage HER2-positive breast cancer: a patient survey M. BradburyMF SavardSF McGee Clinical trial 25 April 2024
Indocyanine green angiography guidance for vascular preservation in skin and nipple sparing mastectomy Thor S. SteadConnie Y. LuJennifer S. Gass Research 25 April 2024
Characteristics and risk factors of axillary lymph node metastasis of microinvasive breast cancer Soo-Young LeeTae-Kyung YooSae Byul Lee Clinical trial 25 April 2024
Impact of HER2 status on clinicopathological characteristics and pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer Yue ShiHeng LuYiqi Zhang Research 24 April 2024
Disentangling the relationships of body mass index and circulating sex hormone concentrations in mammographic density using Mendelian randomization Cameron B. HaasHongjie ChenSara Lindström Epidemiology 24 April 2024
Randomized trials of estrogen-alone and breast cancer incidence: a meta-analysis Rowan T. ChlebowskiAaron K. AragakiJoAnn E. Manson Research 23 April 2024
Racial disparities in outcomes of patients with stage I-III triple-negative breast cancer after adjuvant chemotherapy: a post-hoc analysis of the E5103 randomized trial Saskia LeonardAlyssa N. JonesOlga Kantor Research 23 April 2024
Superior suppression of serum estrogens during neoadjuvant breast cancer treatment with letrozole compared to exemestane Bjørn-Erik BertelsenBjørg AlmåsJürgen Geisler Research Open access 23 April 2024
Ethnic disparities in breast cancer patterns in Brazil: examining findings from population-based registries Jessé Lopes da SilvaLucas Zanetti de AlbuquerqueAndréia Cristina de Melo Research 21 April 2024
Evaluation of markers of immunity in different metastatic immune microenvironments suggests more suppression within breast to liver metastases in breast cancer Robert HsuBatul Al-zubeidyEvanthia T. Roussos Torres Preclinical study Open access 20 April 2024
Sentinel lymph node biopsy before and after neoadjuvant chemotherapy in cN0 breast cancer patients: impact on axillary morbidity and survival—a propensity score cohort study Sergi Fernandez-GonzalezCatalina FaloAmparo Garcia-Tejedor Research Open access 18 April 2024
Tolerability and effectiveness of palbociclib in older women with metastatic breast cancer Joosje C. BaltussenSimon P. MooijaartJohanneke E.A. Portielje Research Open access 16 April 2024
Is postmastectomy radiotherapy necessary for breast cancer patients with clinically node-positive downstaging to ypN0 after neoadjuvant chemotherapy? Chen-feng TanJun WangLei Liu Clinical trial 15 April 2024
Retraction Note: Declining melatonin levels and MT1 receptor expression in aging rats is associated with enhanced mammary tumor growth and decreased sensitivity to melatonin Steven M. HillChi ChengDavid E. Blask Retraction Note 12 April 2024
Uptake of screening and risk-reducing recommendations among women with hereditary breast and ovarian cancer syndrome due to pathogenic BRCA1/2 variants evaluated at a large urban comprehensive cancer center Hadeel AssadMaria LevitinMichael S. Simon Clinical trial 12 April 2024
Correction: Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium Mariana BrandãoDiogo Martins-BrancoEvandro de Azambuja Correction 09 April 2024
STK3 higher expression association with clinical characteristics in intrinsic subtypes of breast cancer invasive ductal carcinoma patients RukhsanaAfia Tasnim SuptyYoungJoo Lee Research 09 April 2024
Recreational physical activity and breast cancer risk by menopausal status and tumor hormone receptor status: results from the Nurses’ Health Studies Renée T. FortnerKristen D. BrantleyA. Heather Eliassen Epidemiology Open access 09 April 2024
Clinical evaluation of deep learning-based risk profiling in breast cancer histopathology and comparison to an established multigene assay Yinxi WangWenwen SunJohan Hartman Research Open access 09 April 2024
Body composition measures as a determinant of Alpelisib related toxicity Eliya ShacharAri RaphaelShlomit Strulov Shachar Research Open access 07 April 2024
Breast cancer (BC) and severe COVID-19 (C-19) outcomes: a matched analysis Marija SullivanXiudong LeiMariana Chavez-MacGregor Epidemiology 06 April 2024
Circulating tumour DNA dynamics during alternating chemotherapy and hormonal therapy in metastatic breast cancer: the ALERT study Rebecca C. AllsoppQi GuoJacqueline A. Shaw Research Open access 06 April 2024
Expression of Cathepsin D in early-stage breast cancer and its prognostic and predictive value Inas AlhudiriChristopher NolanCaroline Chapman Research Open access 05 April 2024
BRCA1/2 mutation carriers vs the general breast cancer population (N = 799,986): 21-gene assay-based molecular characterization Rinat YerushalmiAdi PomerantzLuna Kadouri Clinical trial Open access 03 April 2024
Long-term effects of aromatase inhibitor withdrawal on bone mineral density in early breast cancer patients: 10-year follow-up results of the BREX study Carl BlomqvistLeena VehmanenTiina Saarto Clinical trial Open access 01 April 2024
First-line therapy with palbociclib in patients with advanced HR+/HER2− breast cancer: The real-life study PALBOSPAIN N. Martínez-JañezM. Bellet EzquerraF. Moreno Antón Original Laboratory Investigation Open access 01 April 2024
A whole food, plant-based randomized controlled trial in metastatic breast cancer: feasibility, nutrient, and patient-reported outcomes Erin K. CampbellThomas M. CampbellLuke J. Peppone Clinical trial Open access 30 March 2024
Lifestyle interventions with dietary strategies after breast cancer diagnosis: a systematic review Acadia W. BuroTam NguyenTiffany L. Carson Review 29 March 2024
Ethnic inequities in use of breast conserving surgery and radiation therapy in Aotearoa/New Zealand: which factors contribute? Leah BoyleRoss LawrensonSandar Tin Tin Research Open access 27 March 2024
The effects of low HER2 expression on survival in patients with metastatic breast cancer treated with CDK 4/6 inhibitors: a multicenter retrospective study Murad GuliyevGülin Alkan ŞenNebi Serkan Demirci Research Open access 25 March 2024
Five-year survival prognosis of young, middle-aged, and elderly adult female invasive breast cancer patients by clinical and lifestyle characteristics Yu-Tung TengYong Alison WangJason J. Liu Research Open access 25 March 2024
Comparison of long-term oncologic outcomes of central lumpectomy and conventional breast-conserving surgery for invasive breast cancer: propensity score matching analysis Ji-Jung JungJong-Ho CheunWonshik Han Clinical trial Open access 25 March 2024
Multi-omic profiling of simultaneous ductal carcinoma in situ and invasive breast cancer Henry G. KaplanAlexa K. DowdellBrian D. Piening Preclinical study Open access 24 March 2024
Germline pathogenic variants associated with triple-negative breast cancer in US Hispanic and Guatemalan women using hospital and community-based recruitment strategies Jesica M Godinez ParedesIsabel RodriguezMichael Dean Original Laboratory Investigation Open access 23 March 2024
Racial disparities in initiation of chemotherapy among breast cancer patients with discretionary treatment indication in the state of Georgia Lindsay J. CollinJade JonesLauren E. McCullough Research Open access 22 March 2024
Development of a core set of outcome measures to be applied toward breast cancer-related lymphedema core outcome domains David DoubblesteinLinda KoehlerJane Armer Review Open access 22 March 2024
Trends in socioeconomic inequalities in breast cancer mortality in Canada: 1992–2019 Nazanin NasiriMin HuMohammad Hajizadeh Epidemiology 19 March 2024
The distribution of breast density in women aged 18 years and older Dilukshi PereraSarah PirikahuJennifer Stone Epidemiology Open access 18 March 2024
Retrospective genetic testing (Traceback) in women with early-onset breast cancer after revised national guidelines: a clinical implementation study Annelie AugustinssonNiklas LomanHans Ehrencrona Research Open access 16 March 2024
Global prevalence and factors associated with preoperative depression in women undergoing breast surgery: a meta-analysis and meta-regression Celest Su Yi LeoLing Jie ChengHonggu He Review 16 March 2024
False negative breast cancers on imaging and associated risk factors: a single institution six-year analysis Jordan FranklinJody HayesBaşak Dogan Epidemiology 14 March 2024
Aging-accumulated methylmalonic acid serum levels at breast cancer diagnosis are not associated with distant metastases Qi WuSigrid HatseHans Wildiers Original Laboratory Investigation 13 March 2024